Estudio para evaluar la seguridad, tolerabilidad e inmunogenicidad de V116 en adultos que ya recibieron la vacuna antineumocócica
This a study of V116 in adults ≥50 years of age who previously received a pneumococcal vaccination ≥1 year before enrollment. The primary objectives of this study are to evaluate the